197 related articles for article (PubMed ID: 33142674)
1. Rab11A Functions as a Negative Regulator of Osteoclastogenesis through Dictating Lysosome-Induced Proteolysis of c-fms and RANK Surface Receptors.
Okusha Y; Tran MT; Itagaki M; Sogawa C; Eguchi T; Okui T; Kadowaki T; Sakai E; Tsukuba T; Okamoto K
Cells; 2020 Oct; 9(11):. PubMed ID: 33142674
[TBL] [Abstract][Full Text] [Related]
2. The Inhibitory Role of Rab11b in Osteoclastogenesis through Triggering Lysosome-Induced Degradation of c-Fms and RANK Surface Receptors.
Tran MT; Okusha Y; Feng Y; Morimatsu M; Wei P; Sogawa C; Eguchi T; Kadowaki T; Sakai E; Okamura H; Naruse K; Tsukuba T; Okamoto K
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302495
[TBL] [Abstract][Full Text] [Related]
3. HSP90 drives the Rab11a-mediated vesicular transport of the cell surface receptors in osteoclasts.
Tran MT; Okusha Y; Htike K; Sogawa C; Eguchi T; Kadowaki T; Sakai E; Tsukuba T; Okamoto K
Cell Biochem Funct; 2022 Dec; 40(8):838-855. PubMed ID: 36111708
[TBL] [Abstract][Full Text] [Related]
4. Rab34 plays a critical role as a bidirectional regulator of osteoclastogenesis.
Feng Y; Tran MT; Lu Y; Htike K; Okusha Y; Sogawa C; Eguchi T; Kadowaki T; Sakai E; Tsukuba T; Okamoto K
Cell Biochem Funct; 2022 Apr; 40(3):263-277. PubMed ID: 35285960
[TBL] [Abstract][Full Text] [Related]
5. Rab27A regulates transport of cell surface receptors modulating multinucleation and lysosome-related organelles in osteoclasts.
Shimada-Sugawara M; Sakai E; Okamoto K; Fukuda M; Izumi T; Yoshida N; Tsukuba T
Sci Rep; 2015 Apr; 5():9620. PubMed ID: 25882854
[TBL] [Abstract][Full Text] [Related]
6. Specific targeting of PKCδ suppresses osteoclast differentiation by accelerating proteolysis of membrane-bound macrophage colony-stimulating factor receptor.
Kim MY; Lee K; Shin HI; Jeong D
Sci Rep; 2019 May; 9(1):7044. PubMed ID: 31065073
[TBL] [Abstract][Full Text] [Related]
7. Role of IGF-I signaling in regulating osteoclastogenesis.
Wang Y; Nishida S; Elalieh HZ; Long RK; Halloran BP; Bikle DD
J Bone Miner Res; 2006 Sep; 21(9):1350-8. PubMed ID: 16939393
[TBL] [Abstract][Full Text] [Related]
8. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
[TBL] [Abstract][Full Text] [Related]
9. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors.
Arai F; Miyamoto T; Ohneda O; Inada T; Sudo T; Brasel K; Miyata T; Anderson DM; Suda T
J Exp Med; 1999 Dec; 190(12):1741-54. PubMed ID: 10601350
[TBL] [Abstract][Full Text] [Related]
10. Blocking of the Ubiquitin-Proteasome System Prevents Inflammation-Induced Bone Loss by Accelerating M-CSF Receptor c-Fms Degradation in Osteoclast Differentiation.
Lee K; Kim MY; Ahn H; Kim HS; Shin HI; Jeong D
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946669
[TBL] [Abstract][Full Text] [Related]
11. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
Grcević D; Lukić IK; Kovacić N; Ivcević S; Katavić V; Marusić A
Clin Exp Immunol; 2006 Oct; 146(1):146-58. PubMed ID: 16968409
[TBL] [Abstract][Full Text] [Related]
12. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
13. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
[TBL] [Abstract][Full Text] [Related]
14. Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells.
Yamada T; Yamazaki H; Yamane T; Yoshino M; Okuyama H; Tsuneto M; Kurino T; Hayashi S; Sakano S
Blood; 2003 Mar; 101(6):2227-34. PubMed ID: 12411305
[TBL] [Abstract][Full Text] [Related]
15. Neuromedin B and its receptor silencing suppresses osteoclast generation by modulating precursor proliferation via M-CSF/c-Fms/D-type cyclins.
Yeo CE; Kang WY; Seong SJ; Cho S; Lee HW; Yoon YR; Kim HJ
Exp Cell Res; 2017 Oct; 359(1):112-119. PubMed ID: 28780306
[TBL] [Abstract][Full Text] [Related]
16. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
17. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
18. Rab44, a novel large Rab GTPase, negatively regulates osteoclast differentiation by modulating intracellular calcium levels followed by NFATc1 activation.
Yamaguchi Y; Sakai E; Okamoto K; Kajiya H; Okabe K; Naito M; Kadowaki T; Tsukuba T
Cell Mol Life Sci; 2018 Jan; 75(1):33-48. PubMed ID: 28791425
[TBL] [Abstract][Full Text] [Related]
19. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
20. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]